Example: Heart Attack

Clinical Trials on Centronuclear Myopathy

Total 12 results

NCT03351270

Unknown status

Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies

Conditions: Centronuclear Myopathy
NCT04033159

Recruiting

Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies

Conditions: Centronuclear Myopathy
NCT01817946

Completed

Myotubular Myopathy Genetic Testing Study

Conditions: Myotubular Myopathy
NCT02453152

Completed

Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)

Conditions: X-linked Myotubular Myopathy
NCT02057705

Completed

Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)

Conditions: Myotubular Myopathy
NCT01840657

Completed

Myotubular Myopathy Event Study

Conditions: X-linked Myotubular Myopathy
NCT04064307

Recruiting

Myotubular and Centronuclear Myopathy Patient Registry

Conditions: Myotubular Myopathy; Myotubular Myopathy 1; Myotubular (Centronuclear) Myopathy; Centronuclear Myopathy; Centronuclear Myopathy, X-Linked; X-linked Myotubular Myopathy
NCT03199469

Active, not recruiting

Gene Transfer Clinical Study in X-Linked Myotubular Myopathy

Conditions: X-Linked Myotubular Myopathy
NCT02704273

Completed

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Conditions: X-linked Myotubular Myopathy
NCT02231697

Completed

A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)

Conditions: Males With X-linked Myotubular Myopathy (XLMTM)
NCT00272883

Recruiting

Molecular and Genetic Studies of Congenital Myopathies

Conditions: Central Core Disease; Centronuclear Myopathy; Congenital Fiber Type Disproportion; Multiminicore Disease; Myotubular Myopathy; Nemaline Myopathy; Rigid Spine Muscular Dystrophy; Undefined Congenital Myopathy
NCT01403402

Unknown status

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

Conditions: Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed); Dystroglycanopathy; Congenital Fiber Type Disproportion; Rigid Spine Muscular Dystrophy; Congenital Myopathy (Including Unspecified/Undiagnosed); Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy); Laminin Alpha 2 Related Congenital Muscular Dystrophy; LAMA2-CMD/Merosin Deficient/MDC1A; Walker-Warburg Syndrome; Muscle-Eye-Brain Disease; Fukuyama/Fukutin Related Muscular Dystrophy; Integrin Alpha 7 Deficiency; Integrin Alpha 9 Deficiency; LMNA-CMD/Lamin A/C/Laminopathy; SEPN1-Related Myopathy; Bethlem Myopathy; Actin Aggregation Myopathy; Cap Disease; Central Core Disease; Centronuclear Myopathy; Core Rod Myopathy; Hyaline Body Myopathy; Multiminicore Myopathy; Myotubular Myopathy; Nemaline Myopathy; Tubular Aggregate Myopathy; Zebra Body Myopathy; Reducing Body Myopathy; Spheroid Body Myopathy; LGMD1B (LMNA); LGMD1E (DES); LGMD2G (TCAP); LGMD2H (TRIM32); LGMD2I (FKRP); LGMD2J (TTN); LGMD2K (POMT1); LGMD2M (FKTN); LGMD2N (POMT2); LGMD2O (POMGnT1); LGMD2P (DAG1); LGMD2Q (PLEC1); LGMD2R (DES); LGMD2S (TRAPPC11); LGMD2T (GMPPB); LGMD2U (ISPD); LGMD2V (GAA); Ullrich Congenital Muscular Dystrophy; Titinopathy; Choline Kinase B Receptor; Emery-Dreifuss Muscular Dystrophy; RYR1 Related Myopathy; SYNE1/Nesprin Related Muscular Dystrophy; Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap); Congenital Myasthenic Syndrome; Escobar Syndrome; Myofibrillar Myopathy; Malignant Hyperthermia; Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN); Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1); Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other)